A CASE REPORT OF NEUROLEPTIC MALIGNANT SYNDROME INDUCED BY CLOZAPINE IS NEUROLEPTIC MALIGNANT SYNDROME DIAGNOSTIC CRITERIA ADEQUATELY SENSITIVE TO IDENTIFY DIVERSE FEATURES OF THE SYNDROME?

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

AHMADKHANIHA H.R.; TAYEBI A.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Psychiatry and Behavioral Sciences Year:2009 | Volume:2 | Issue:2 Page(s): 50-54

Download Full-Text

View:

328

Download:

314

Cites:

Information Journal Paper

Title

A CASE REPORT OF NEUROLEPTIC MALIGNANT SYNDROME INDUCED BY CLOZAPINE IS NEUROLEPTIC MALIGNANT SYNDROME DIAGNOSTIC CRITERIA ADEQUATELY SENSITIVE TO IDENTIFY DIVERSE FEATURES OF THE SYNDROME?

Author(s)

AHMADKHANIHA H.R. | TAYEBI A. | Issue Writer Certificate

Keywords

ATYPICAL ANTIPSYCHOTIC

CLOZAPINE

NEUROLEPTIC MALIGNANT SYNDROME

Abstract

neuroleptic Malignant Syndrome (NMS) is a rare fatal medical complication that occurs as a result of dopaminergic receptor blockage in the caudate at the termination of the nigrostriatal pathways, and may occur at any time following consumption of dopamine antagonists. This disorder also occurs in cases of sudden discontinuation of dopamine agonists and antagonists. Some studies have also reported the syndrome following tricyclic antidepressants (TCAs) or specific serotonin reuptake inhibitors (SSRIs) use.

Cites

No record.

References

No record.

Cite

APA: Copy

AHMADKHANIHA, H.R., & TAYEBI, A.. (2009). A CASE REPORT OF NEUROLEPTIC MALIGNANT SYNDROME INDUCED BY CLOZAPINE IS NEUROLEPTIC MALIGNANT SYNDROME DIAGNOSTIC CRITERIA ADEQUATELY SENSITIVE TO IDENTIFY DIVERSE FEATURES OF THE SYNDROME?. IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES (IJPBS), 2(2), 50-54. SID. https://sid.ir/paper/311863/en

Vancouver: Copy

AHMADKHANIHA H.R., TAYEBI A.. A CASE REPORT OF NEUROLEPTIC MALIGNANT SYNDROME INDUCED BY CLOZAPINE IS NEUROLEPTIC MALIGNANT SYNDROME DIAGNOSTIC CRITERIA ADEQUATELY SENSITIVE TO IDENTIFY DIVERSE FEATURES OF THE SYNDROME?. IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES (IJPBS)[Internet]. 2009;2(2):50-54. Available from: https://sid.ir/paper/311863/en

IEEE: Copy

H.R. AHMADKHANIHA, and A. TAYEBI, “A CASE REPORT OF NEUROLEPTIC MALIGNANT SYNDROME INDUCED BY CLOZAPINE IS NEUROLEPTIC MALIGNANT SYNDROME DIAGNOSTIC CRITERIA ADEQUATELY SENSITIVE TO IDENTIFY DIVERSE FEATURES OF THE SYNDROME?,” IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES (IJPBS), vol. 2, no. 2, pp. 50–54, 2009, [Online]. Available: https://sid.ir/paper/311863/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops